Tag: therapeutic drug monitoring market

  • Insights Into The Therapeutic Drug Monitoring Market’s Growth Potential 2024-2033

    Insights Into The Therapeutic Drug Monitoring Market’s Growth Potential 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate is Forecasted for the Therapeutic Drug Monitoring Market over the 2024-2033 Period?

    The market size for therapeutic drug monitoring has witnessed robust growth in the past few years. The market, valued at $2.1 billion in 2023, is projected to boost to $2.29 billion in 2024, with a compound annual growth rate (CAGR) of 9.2%. The escalation during the previous period can be associated with the surge in chronic diseases, concerns about drug safety, integration of pharmacogenomics, augmentation in drug development, and regulatory focus on precision medicine.

    In the coming years, the therapeutic drug monitoring market size is poised for significant expansion. It is projected to rise to $3.36 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 10.1%. This growth during the forecasted timeline is due to factors such as the wider scope of applications in oncology, an increase in personalized medicine practices, a globally aging population, more extensive point-of-care testing, and a rise in pharmaceutical R&D spending. The anticipated trends for the forecasted period encompass personalized medicine, technological progress, heightened drug development and usage, point-of-care testing (poct), as well as emerging biomarkers and assay technologies.

    Claim Your Free Sample of the Global Therapeutic Drug Monitoring Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

    Which Factors Are Stimulating Growth in the therapeutic drug monitoring Market?

    The therapeutic drug monitoring market is predicted to grow due to the surge in organ transplant surgeries. The procedure of moving an organ from a donor to another person is known as organ transplantation. TDM of immunosuppressive drugs is recognized as a potent management style for patients who undergo solid organ transplantation. Optimizing TDM could help to sidestep excessively toxic or low-dose therapy, which could cause organ rejection. For instance, an article published by the United Network for Organ Sharing in January 2023, an organization based in the US that manages organ transplant operations, reported that there was a 3.7% hike in organ transplants in the US in 2022, with 42,887 procedures carried out, compared to 2021. Hence, the incremental organ transplant surgeries are fuelling the growth of the therapeutic drug monitoring market.

    What Are the Main Segments of the Therapeutic Drug Monitoring Market?

    1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

    2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms

    3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs

    4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

    What Innovative Trends Are Redefining the Therapeutic Drug Monitoring Landscape?

    Major therapeutic drug monitoring market players are prioritizing product innovations to cater to customer requirements and bolster their market presence, marking a substantial trend. Promise Proteomics, located in France, unveiled their mAbXmise kits in October 2021. The unique product amalgamates labelled monoclonal antibodies, reagents, and laboratory supplies, specifically designed to quantify therapeutic monoclonal antibodies via mass spectrometry, surpassing the capabilities of preceding analytical processes. This multiplexing technique not only offers unparalleled scientific, clinical, and economic insights, but also sufficiently addresses the constraints of routine therapeutic drug monitoring.

    Order Now for Fast Delivery of Your Therapeutic Drug Monitoring Market Report!

    https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

    Which Regions Are Key Players in the Growth of the Therapeutic Drug Monitoring Market?

    North America was the largest region in the therapeutic drug monitoring market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Therapeutic Drug Monitoring Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the therapeutic drug monitoring market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Therapeutic Drug Monitoring Market Include

    1. Therapeutic Drug Monitoring Market Executive Summary

    2. Therapeutic Drug Monitoring Market Segments

    3. Therapeutic Drug Monitoring Market Size And Template Market Growth Rate

    4. Key Therapeutic Drug Monitoring Market Trends

    5. Major Therapeutic Drug Monitoring Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Therapeutic Drug Monitoring Market

    26. Top Therapeutic Drug Monitoring Companies

    27. Therapeutic Drug Monitoring Market Opportunities And Strategies

    28. Therapeutic Drug Monitoring Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Food and Beverage Testing Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/food-and-beverage-testing-kits-global-market-report

    Cookie, Cracker, Pasta, And Tortilla Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cookie-cracker-pasta-and-tortilla-global-market-report

    Sign Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/sign-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Will The Therapeutic Drug Monitoring Market Globally Expand In 2023?

    How Will The Therapeutic Drug Monitoring Market Globally Expand In 2023?

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

    The Business Research Company’s therapeutic drug monitoring market report forecasts the therapeutic drug monitoring market size to grow to $3.03 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

    Learn More On The Therapeutic Drug Monitoring Market Report 2023 – https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

    Therapeutic Drug Monitoring Market Size Forecast
    The global therapeutic drug monitoring market is expected to grow from $1.93 billion in 2022 to $2.10 billion in 2023 at a compound annual growth rate (CAGR) of 8.83%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global therapeutic drug monitoring market size is expected to reach $3.03 billion in 2027 at a CAGR of 9.66%.

    North America held the largest therapeutic drug monitoring market share, and Asia-Pacific was the fastest-growing region in 2022.

    Key Therapeutic Drug Monitoring Market Driver ­– Rise In Organ Transplant Surgeries
    According to an article published in January 2023 by the United Network for Organ Sharing, a non-profit organisation based in the United States responsible for managing organ transplants, 42,887 organ transplants were done in the United States in 2022, a 3.7% increase over 2021. As a result, the therapeutic drug monitoring market is being driven by the increase in organ transplant surgeries.

    Request for A Sample Of The Global Therapeutic Drug Monitoring Market Report:
    https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

    Key Therapeutic Drug Monitoring Market Trend – Product Innovations
    Major therapeutic drug monitoring firms are focusing on developing new products to suit customer demands and expand their market position. Promise Proteomics, a proteomics firm based in France, announced mAbXmise kits in October 2021, a patented solution that contains labelled monoclonal antibodies, reagents, and laboratory supplies for quantifying therapeutic monoclonal antibodies by mass spectrometry. This multiplexing technology exceeds prior analytical methods, providing scientific, clinical, and economic views that fully meet the constraints of routine therapeutic drug monitoring.

    Therapeutic Drug Monitoring Market Segment
    1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
    2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
    3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
    4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

    Therapeutic Drug Monitoring Market Major Players and Strategies
    Major players in the therapeutic drug monitoring market are Abbott Laboratories Inc, Hoffmann-La Roche Ltd, Siemens Healthineers Inc., Thermo Fisher Scientific Inc., Sekisui Medical Co, Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, OraSure Technologies, and BioChem Pharmaceuticals.

    Sentinel Diagnostics, an Italian in vitro diagnostic business, paid an unknown sum for Eureka S.r.l. in February 2023. Sentinel Diagnostics is now a large producer and developer of IVD diagnostics, thanks to this acquisition. Sentinel Diagnostics’ enhanced capabilities will enable it to supply clinical laboratories with a broader range of assays, ranging from high-throughput core lab tests to the most cutting-edge, specialised second-level assays. EUREKA S.r.l. is a chromatographic IVD firm based in Italy that offers ready-to-use diagnostic kits for HPLC, GC, GC-MS, and LC-MS/MS applications in specific clinical chemistry, therapeutic drug monitoring, occupational toxicology, and forensic toxicology.

    The Therapeutic Drug Monitoring Global Market Report 2023 covers regional data on therapeutic drug monitoring market size, therapeutic drug monitoring market trends and drivers, opportunities, strategies, and therapeutic drug monitoring market competitor analysis. The countries covered in the therapeutic drug monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

    Therapeutic drug monitoring (TDM) is a clinical practise in which the concentration of a certain medicine in a patient’s bloodstream is continuously checked to ensure that their dosing regimens are working properly. It is used to monitor pharmaceuticals with difficult-to-monitor target concentrations, medications with high pharmacokinetic variability, medications with known therapeutic and unfavourable side effects, and medications with limited therapeutic ranges.

    View More Reports Related To The Therapeutic Drug Monitoring Market –
    Therapeutic Dental Equipment Global Market Report 2023
    Therapeutic Proteins Global Market Report 2023
    Drugs For Immunotherapy Global Market Report 2023

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas
    +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Therapeutic Drug Monitoring Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Therapeutic Drug Monitoring Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The therapeutic drug monitoring market has witnessed robust growth in recent years, driven by a myriad of factors including rising chronic diseases, drug safety concerns, and advancements in pharmacogenomics. With expanding applications and emerging trends, the market presents significant opportunities and challenges.

    Market Size and Growth Projections

    • The therapeutic drug monitoring market is on a growth trajectory, expected to reach $2.29 billion in 2024 at a CAGR of 9.2% from $2.1 billion in 2023.
    • Projections indicate rapid expansion to $3.36 billion by 2028, fueled by the rising demand for personalized medicine and advancements in point-of-care testing.

    Organ Transplant Surge Drives Market Growth

    • The rise in organ transplant surgeries has emerged as a key driver of the therapeutic drug monitoring market.
    • Therapeutic drug monitoring optimizes immunosuppressive therapy, mitigating risks of organ rejection and toxic drug levels.
    • Major companies in the market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, and Siemens Healthineers AG, among others, contributing to market growth through innovative solutions.

    Innovative Solutions Drive Market Growth

    • Product innovations play a pivotal role in shaping the therapeutic drug monitoring market landscape.
    • Companies such as Promise Proteomics and Sentinel Diagnostics are developing novel solutions to meet evolving customer needs and strengthen market positions.
    • Sentinel Diagnostics’ acquisition of Eureka S.r.l. underscores the importance of expanding capabilities and portfolio diversification in the rapidly evolving IVD testing landscape.

    Market Segmentation and Regional Insights

    • The therapeutic drug monitoring market is segmented by product, technology, class of drug, and end-user.
    • North America dominated the market in 2023, with Asia-Pacific poised for the fastest growth during the forecast period.

    Conclusion: Embracing Innovation and Collaboration
    The therapeutic drug monitoring market presents lucrative opportunities for stakeholders amidst evolving trends and growth projections. As the market continues to expand, driven by rising chronic diseases and advancements in drug monitoring technologies, stakeholders must prioritize innovation, strategic partnerships, and regulatory compliance. By embracing these strategies, stakeholders can navigate the dynamic landscape of the therapeutic drug monitoring market and contribute to improving patient outcomes and healthcare efficacy globally.

    View More On The Therapeutic Drug Monitoring Market Report 2024 – https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

    Request A Sample Of The Global Therapeutic Drug Monitoring Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=10069&type=smp